Trademark Overview
On Friday, January 30, 2026, a trademark application was filed for TRIMGLUE with the United States Patent and Trademark Office. The USPTO has given the TRIMGLUE trademark a serial number of 79445720. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 12, 2026. This trademark is owned by TRIMTECH Therapeutics Limited. The TRIMGLUE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and medical preparations and substances; preparations for use in targeted and personalized pharmaceutical therapies; pharmaceutical preparations and substances for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; biopharmaceuticals for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; drugs for medical purposes; oral drugs for medical purposes; drugs for medical use for the degradation of toxins; pharmaceutical preparations in the fields of medicine, health, neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; biological preparations for medical purposes; biological compounds for use in targeted and personalized pharmaceutical therapies; proteins, reagents and cultures, all for medical purposes; proteins with diagnostic and therapeutic uses; drug delivery agents that facilitate the delivery of pharmaceutical p...
Drug development services; scientific consultancy; laboratory services; provision of information and data relating to medical research and development; medical and pharmacological research and development services; scientific research; biochemical and biological research; clinical research; laboratory research; research and development services in the field of medical therapeutics, including in the fields of neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; research and development services in the field of drug development, protein testing, and degradation of aggregated proteins; research, development and design of scientific and medical testing and screening products; scientific testing services; biological testing; information, consultancy and advisory services relating to the aforesaid.
